Samarra: The General Company for Pharmaceutical Industries and Medical Supplies in Samarra, affiliated with the Ministry of Industry and Minerals, has successfully supplied the Ministry of Health with over 42,000 strips of Dapaxocin tablets. These tablets, each with a dosage of 5 mg, are intended for the treatment of type 2 diabetes, as per the agreement established between the two parties.

According to National Iraqi News Agency, the Director General of the company, Muhammad Abdul Qadir Al-Nuaimi, emphasized that the Dapaxocin tablets are manufactured following the latest international standards. The production process involves the use of raw materials from reputable sources and is subjected to a comprehensive series of laboratory tests and quality control procedures at every stage to ensure the product’s quality and effectiveness in treatment.

Al-Nuaimi further highlighted the company’s ongoing commitment to bolstering the health sector by supplying high-quality national medicines. This effort plays a vital role in enhancing national pharmaceutical security.